Abstract:Rationale: Developing an effective nanoplatform to realize 'multi-in-one' is essential to broaden the therapeutic potential of combination therapy. Exosomes are ideal candidates since their intrinsic abilities of integrating multiple contents and functions. However, only limited efforts have been devoted to engineering exosomes to integrate the needed properties, also considering the safety and yield, for tumor-targeted and efficient gene/chemo combination therapy.Methods: Herein, by manipulating the exosome membrane, blood exosomes with high abundance and safety are engineered as a versatile combinatorial delivery system, where the doxorubicin (Dox) and cholesterol-modified miRNA21 inhibitor (miR-21i) are co-embedded into the lipid bilayer of exosomes, and the magnetic molecules and endosomolytic peptides L17E are bind to the exosome membrane through ligand-receptor coupling and electrostatic interactions, respectively.Results: It is proved that such engineering strategy not only preserves their intrinsic features, but also readily integrates multiple properties of tumor targeting, efficient transfection and gene/chemo combination therapy into blood exosomes. The lipid bilayer structure of exosomes allows them to co-load Dox and miR-21i with high-payloads. Moreover, profiting from the integration of magnetic molecules and L17E peptides, the engineered exosomes exhibit an enhanced tumor accumulation and an improved endosome escape ability, thereby specifically and efficiently delivering encapsulated cargos to tumor cells. As a result, a remarkable inhibition of tumor growth is observed in the tumor-bearing mice, and without noticeable side effects.Conclusions: This study demonstrates the potential of engineered blood exosomes as feasible co-delivery nanosystem for tumor-targeted and efficient combination therapy. Further development by replacing the drugs combined regimens can potentially make this engineered exosome become a general platform for the design of safe and effective combination therapy modality.

Engineered Exosome-Based Drug Delivery System for Synergistic Cancer Therapy Via Autophagy Inhibition and Chemotherapy

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy

High-throughput single-cell analysis of exosome mediated dual drug delivery,<i>in vivo</i>fate and synergistic tumor therapy

Engineered Exosomes as Theranostic Platforms for Cancer Treatment

Designer Exosomes Enabling Tumor Targeted Efficient Chemo/gene/photothermal Therapy

Exosome Mediated Multidrug Resistance in Cancer.

Engineered Exosomes As Drug and RNA Co-Delivery System: New Hope for Enhanced Therapeutics?

Responsive Exosome Nano‐bioconjugates for Synergistic Cancer Therapy

Advances in engineered exosomes towards cancer diagnosis and therapeutics

Combinational antitumor strategies of exosomes as drug carriers: Mini review

Application of exosome engineering modification in targeted delivery of therapeutic drugs

Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy

Cancer cell-derived exosome based dual-targeted drug delivery system for non-small cell lung cancer therapy

Engineered exosomes as a natural nanoplatform for cancer targeted delivery of metal-based drugs

Biomimetic Engineered Nanoparticles Target Drug-Resistant Tumor Cells and Heterogeneous Blood Vessels for Combination Therapy of Osteosarcoma

Exosomes As Actively Targeted Nanocarriers for Cancer Therapy

Tumor Exosome Mimicking Nanoparticles for Tumor Combinatorial Chemo-Photothermal Therapy

Engineered exosomes from different sources for cancer-targeted therapy

Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells.

Exosomes As Drug Carriers for Clinical Application

Exosomes: Promising Nanocarrier for Cancer Therapy